Invesco’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Buy
136,462
+81,573
+149% +$173K ﹤0.01% 3299
2025
Q4
$113K Sell
54,889
-4,828
-8% -$13.9K ﹤0.01% 3622
2025
Q3
$207K Sell
59,717
-12,577
-17% -$35.1K ﹤0.01% 3556
2025
Q2
$159K Sell
72,294
-14,608
-17% -$23.9K ﹤0.01% 3571
2025
Q1
$101K Sell
86,902
-13,262
-13% -$19.5K ﹤0.01% 3624
2024
Q4
$127K Buy
100,164
+8,448
+9% +$21.5K ﹤0.01% 3595
2024
Q3
$313K Buy
91,716
+4,263
+5% +$18.6K ﹤0.01% 3402
2024
Q2
$408K Buy
87,453
+492
+0.6% +$2.77K ﹤0.01% 3358
2024
Q1
$645K Sell
86,961
-3,492
-4% -$29K ﹤0.01% 3205
2023
Q4
$916K Buy
90,453
+7,786
+9% +$68.3K ﹤0.01% 2934
2023
Q3
$645K Buy
82,667
+2,481
+3% +$21.3K ﹤0.01% 3079
2023
Q2
$660K Buy
80,186
+1,360
+2% +$11.8K ﹤0.01% 3104
2023
Q1
$571K Buy
78,826
+23,051
+41% +$205K ﹤0.01% 3187
2022
Q4
$495K Sell
55,775
-227
-0.4% -$2.49K ﹤0.01% 3270
2022
Q3
$685K Sell
56,002
-1,790
-3% -$27.9K ﹤0.01% 3078
2022
Q2
$683K Buy
57,792
+1,591
+3% +$21.3K ﹤0.01% 3180
2022
Q1
$1.07M Buy
56,201
+20,712
+58% +$385K ﹤0.01% 3038
2021
Q4
$942K Sell
35,489
-2,867
-7% -$98.7K ﹤0.01% 3093
2021
Q3
$1.58M Buy
38,356
+4,838
+14% +$265K ﹤0.01% 2919
2021
Q2
$1.9M Buy
33,518
+11,641
+53% +$430K ﹤0.01% 2873
2021
Q1
$919K Sell
21,877
-17,920
-45% -$1.02M ﹤0.01% 3082
2020
Q4
$2.79M Buy
39,797
+27,156
+215% +$1.12M ﹤0.01% 2474
2020
Q3
$355K Sell
12,641
-141
-1% -$4.59K ﹤0.01% 3256
2020
Q2
$378K Sell
12,782
-1,077
-8% -$28.1K ﹤0.01% 3255
2020
Q1
$274K Buy
13,859
+3,252
+31% +$82K ﹤0.01% 3299
2019
Q4
$314K Sell
10,607
-701
-6% -$17.5K ﹤0.01% 3409
2019
Q3
$257K Sell
11,308
-444
-4% -$11K ﹤0.01% 3475
2019
Q2
$291K Sell
11,752
-414
-3% -$9.88K ﹤0.01% 3512
2019
Q1
$297K Sell
12,166
-24,892
-67% -$563K ﹤0.01% 3493
2018
Q4
$843K Buy
+37,058
New +$1.01M ﹤0.01% 3071
2017
Q4
Sell
-331,547
Closed -$7.96M 3645
2017
Q3
$7.96M Buy
+331,547
New +$6.31M ﹤0.01% 1701

Other funds holding EDIT